AI Verdict
OSPN has stronger fundamentals based on our AI analysis.
OSTX vs OSPN Fundamental Comparison
| Metric | OSTX | OSPN |
|---|---|---|
| Revenue | N/A | $243.2M |
| Net Income | $-28.8M | $72.9M |
| Net Margin | N/A | 30.0% |
| ROE | N/A | 26.8% |
| ROA | -420.4% | 18.3% |
| Current Ratio | 0.03x | 1.50x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.98 | $1.88 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OSTX vs OSPN: Frequently Asked Questions
Is OSTX or OSPN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OSPN has stronger fundamentals. OSTX is rated STRONG SELL (95% confidence) while OSPN is rated HOLD (82% confidence). This is not investment advice.
How does OSTX compare to OSPN fundamentally?
OS Therapies Inc has ROE of N/A vs OneSpan Inc.'s 26.8%. Net margins are N/A vs 30.0% respectively.
Which stock pays higher dividends, OSTX or OSPN?
OSTX has a dividend yield of N/A or no dividend while OSPN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OSTX or OSPN for long term?
For long-term investing, consider that OSTX has STRONG SELL rating with 95% confidence, while OSPN has HOLD rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OSTX vs OSPN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OSTX vs OSPN, the AI consensus favors OSPN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.